OVAL MEDICAL ADMINISTRATION LTDActive

Company number 14433665Private limited companyIncorporated 2022

Key figures

£5,714-8.7%
Net assets 2024/25
+14.6%
Average annual growth 2022/23–2024/25
02 k4 k6 k8 k2022/232023/242024/25

Like most small UK companies, OVAL MEDICAL ADMINISTRATION LTD does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
02.5 k5 k7.5 k2022/232023/242024/25

Dividends

from the accounts
2023/24

Dividends paid in the financial year: £2,000 (88% of the profit for the year).

Filed accounts2022/23–2024/25
2022/232023/242024/25
Turnover—7,177—
Profit for the year—2,284—
Cash at bank and in hand—6,756—
Total assets5,9726,7565,714
Total liabilities1,0205000
Net assets / total equity4,3526,2565,714
Average number of employees200
Dividends paid—2,000—

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: OVAL MEDICAL ADMINISTRATION LTD

Company

OVAL MEDICAL ADMINISTRATION LTD is a private limited company registered with Companies House under company number 14433665. It was incorporated on 20 Oct 2022. Its status is active. The registered office is in London (NW10). Its nature of business (SIC 2007) is combined office administrative service activities (82110).

Accounts

The latest accounts in the database are for 2024/25 (period ending 31 Oct 2025); the company files micro-entity accounts. Net assets were £5,714, down 8.7% on the previous year. Total assets were £5,714 and total liabilities £0. The company had an average of 0 employees. Figures are available for 3 financial years (2022/23–2024/25).

Control and charges

2 persons with significant control are registered.

Filing deadlines

The next accounts are due by 31 Jul 2027. The next confirmation statement is due by 2 Nov 2026.